Results 171 to 180 of about 4,397 (213)
Stroke risk following bee and wasp stings: a systematic review of ischemic and hemorrhagic events. [PDF]
Front ToxicolVasconez-Gonzalez J +7 more
europepmc +1 more source
Basophil activation test in Hymenoptera venom allergy. [PDF]
Allergol SelectEberlein B +4 more
europepmc +1 more source
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani. [PDF]
PLoS Negl Trop DisEdge RJ +10 more
europepmc +1 more source
Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents. [PDF]
Toxins (Basel)Rabea EY +10 more
europepmc +1 more source
Pattern of sensitization to yellow jacket venom and expression of recombinant antigen 5 (Ves v 5) from yellow jacket venom. [PDF]
BMC ImmunolMahmoudzadeh S +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Journal of Australia, 1980
To the Editor.— Regarding the COMMENTARY by Lichtenstein et al elsewhere in this issue (p 1683), the basic question is can one justify immunotherapy to protect against the following: 1. A disease with an almost zero mortality when those at mortal risk have not been identified?
openaire +3 more sources
To the Editor.— Regarding the COMMENTARY by Lichtenstein et al elsewhere in this issue (p 1683), the basic question is can one justify immunotherapy to protect against the following: 1. A disease with an almost zero mortality when those at mortal risk have not been identified?
openaire +3 more sources
Clinical Reviews in Allergy & Immunology, 2017
Bee venom is a blend of biochemicals ranging from small peptides and enzymes to biogenic amines. It is capable of triggering severe immunologic reactions owing to its allergenic fraction. Venom components are presented to the T cells by antigen-presenting cells within the skin.
Daniel, Elieh Ali Komi +2 more
openaire +2 more sources
Bee venom is a blend of biochemicals ranging from small peptides and enzymes to biogenic amines. It is capable of triggering severe immunologic reactions owing to its allergenic fraction. Venom components are presented to the T cells by antigen-presenting cells within the skin.
Daniel, Elieh Ali Komi +2 more
openaire +2 more sources
Polymerized insoluble bee venom
Journal of Allergy and Clinical Immunology, 1980Using a polymerization process previously used for ragweed allergens, honeybee venom was polymerized. Instead of soluble polymers, an insoluble precipitate, polymerized insoluble bee venom (PIBV), is the result. A major allergen of honeybee venom, 125I phospholipase A (PL-A) incorporated into PIBV, was shown to have decreased dissemination from ...
R, Patterson +4 more
openaire +2 more sources
Cancer and Metastasis Reviews, 2011
Bee venom (BV) (api-toxin) has been widely used in the treatment of some immune-related diseases, as well as in recent times in treatment of tumors. Several cancer cells, including renal, lung, liver, prostate, bladder, and mammary cancer cells as well as leukemia cells, can be targets of bee venom peptides such as melittin and phospholipase A2.
openaire +4 more sources
Bee venom (BV) (api-toxin) has been widely used in the treatment of some immune-related diseases, as well as in recent times in treatment of tumors. Several cancer cells, including renal, lung, liver, prostate, bladder, and mammary cancer cells as well as leukemia cells, can be targets of bee venom peptides such as melittin and phospholipase A2.
openaire +4 more sources